India Infoline1 小时
Biocon Shares Surge on USFDA VAI Designation
The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...
Business Standard1 小时
Biocon soars after USFDA classifies Bengaluru unit as VAI
Biocon jumped 5.93% to Rs 340.30 after the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities at Biocon Park in Bengaluru, as 'voluntary action indicated' (VAI). The ...
Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI
Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47 ...
Jewish Press8 小时
TAU Researchers Show Damaged Brains of PTSD Victims Respond to Hyperbaric Therapy
In many cases, PTSD is resistant to psychotherapy and common psychiatric medications. Past studies on therapy-resistant sufferers have found changes in the structure and function of brain tissues, or ...
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
Knowridge1 天
Taking five or more drugs daily may harm health in people with Alzheimer’s
Taking five or more medications daily, known as polypharmacy, is a growing issue for over 30% of older adults. This practice ...
AbCellera Biologics (NASDAQ:ABCL) Earns “Hold” Rating from Benchmark
Benchmark restated their hold rating on shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) in a research note published on Tuesday morning,Benzinga reports. ABCL has been the topic of a number ...